A Dose-Escalation Study for Patients With Advanced Cancer

Clinical trial NCT01214642 · COMPLETED

Trial details

NCT number: NCT01214642
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2008-05-01
Primary completion: 2011-12-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.